Solara Active Pharma Sciences share news and announcements
NSE: SOLARABSE: 541540Pharmaceuticals & BiotechnologySmall Cap
Last close ₹611.55down ₹7.50 (1.21%)BSE ₹612.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹619.05.
52-week range of traded prices to 23 Oct 2026
₹422.00Low, 30 Mar 2026₹774.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹2,951 Cr1,182nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 16 Oct 2026
- 79.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 62.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 16 Oct 2026
- 2.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 16 Oct 2026
- 2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 16 Oct 2026
- 6.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 16 Oct 2026
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 5,34,15343.0% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Solara Active Pharma Sciences quarterly results
Oct16Fri
The board met on 16 Oct 2026 to consider financial results
Notice filed 9 Oct 2026
Solara Active Pharma Sciences annual reports, presentations and earnings calls
The company's own documents, latest first.Solara Active Pharma Sciences financials, year by year
Annual reports8
- Annual report, year to Mar 2026 (opens in a new tab)25 Aug 2026
- Annual report, year to Mar 2025 (opens in a new tab)2 Sep 2025
- Annual report, year to Mar 2024 (opens in a new tab)26 Sep 2024
- Annual report, year to Mar 2022 (opens in a new tab)5 Sep 2022, a zip file
- Annual report, year to Mar 2021 (opens in a new tab)30 Jul 2021, a zip file
3 earlier reports
- Annual report, year to Mar 2020 (opens in a new tab)7 Jul 2020, a zip file
- Annual report, year to Mar 2019 (opens in a new tab)19 Jul 2019, a zip file
- Annual report, year to Mar 2018 (opens in a new tab)4 Oct 2018, a zip file
Investor presentations5
- Updated Investor Presentation (opens in a new tab)2 May 2022
- Investor Presentation (opens in a new tab)11 Apr 2021
- Investor Presentation (opens in a new tab)14 May 2020
- Investor Presentation on Intimation of Analysts / Institutional Investors Conference Call (opens in a new tab)4 May 2020
- Investor Presentation (opens in a new tab)14 Oct 2019
Earnings calls38
- Transcript of Earnings Conference call pertaining to financial results of the Company for the quarter ended September 30, 2026 (opens in a new tab)23 Oct 2026
- Audio recordings of Q2 FY27 earnings call conducted on October 16, 2026, for the quarter ended September 30, 2026 (opens in a new tab)16 Oct 2026
- Transcript of Earnings conference call pertaining to financial results of the Company for the quarter ended June 30, 2026 (opens in a new tab)29 Jul 2026
- Audio Recording of the Q1 FY27 Earnings Call held on July 23, 2026 at 16.00 IST (opens in a new tab)23 Jul 2026
- Transcript of earnings conference call pertaining to financial results of the Company for the quarter and year ended March 31, 2026. (opens in a new tab)21 May 2026
33 earlier call documents
- Audio Recording of the Q4 FY26 Earnings Call held on May 15, 2026 at 15.00 IST. (opens in a new tab)15 May 2026
- Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31, 2025. (opens in a new tab)10 Feb 2026
- Audio Recording of the Q3 FY26 Earnings Call held on February 06, 2026. (opens in a new tab)6 Feb 2026
- Earnings call Transcript pertaining to the unaudited financials for the quarter and half year ended September 30, 2025. (opens in a new tab)11 Nov 2025
- Audio recording of Q2 FY26 earnings call held on November 05, 2025. (opens in a new tab)5 Nov 2025
- Earnings Call Transcript for the Analysts/Investors Conference Call held on Friday, July 25, 2025. (opens in a new tab)29 Jul 2025
- Link of Recording of the Investors meet held on 25th July 2025 for the quarter ended June 30, 2025. (opens in a new tab)25 Jul 2025
- Earnings Call Transcript of Analysts/Investors Conference Call held on May 15, 2025 (opens in a new tab)21 May 2025
- Link of Recording (opens in a new tab)15 May 2025
- Earnings Call Transcript for the Board Meeting held on January 24, 2025 (opens in a new tab)31 Jan 2025
- Audio Link of Recording of the Financial Results for the quarter ended December 31, 2024 (opens in a new tab)24 Jan 2025
- Earnings Call Transcript for the Board Meeting held on October 21, 2024. (opens in a new tab)28 Oct 2024
- Link of Recording of the Investor's Call in connection with the Unaudited Financial Results for the quarter ended September 30, 2024 (opens in a new tab)21 Oct 2024
- Transcript (opens in a new tab)26 Jul 2024
- Link of Recording (opens in a new tab)22 Jul 2024
- Transcript (opens in a new tab)4 Jun 2024
- Link of Recording (opens in a new tab)29 May 2024
- Transcript (opens in a new tab)21 Feb 2024
- Link of Recording (opens in a new tab)14 Feb 2024
- Transcript (opens in a new tab)20 Nov 2023
- Link of Recording (opens in a new tab)14 Nov 2023
- Transcript (opens in a new tab)21 Aug 2023
- Link of Recording (opens in a new tab)14 Aug 2023
- Transcript (opens in a new tab)18 May 2023
- Link of Recording (opens in a new tab)12 May 2023
- Transcript (opens in a new tab)1 Feb 2023
- Link of Recording (opens in a new tab)25 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)15 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)9 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)10 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)4 Aug 2022
- Transcript of Earnings Conference call. (opens in a new tab)6 May 2022
- Audio Recording of Analysts/Institutional Investor Meet/Con. Call Held on April 29, 2022. (opens in a new tab)30 Apr 2022
Solara Active Pharma Sciences share news and announcements
531 announcements, routine notices left out, newest first. Page 1 of 11.
Oct 2026
10 Oct · General Updates
Sep 2026
Aug 2026
Jul 2026
Jun 2026
23 Jun · Rating
10 Jun · Legal
The exchange asked on 9 Jun 2026
May 2026
15 May · General Updates
12 May · Analysts
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 16 Oct 2026Resultsup 7.38%+7.0 pts vs Nifty 500market median −0.7% · volume 20.2× usual · delivery −30.3 pts against usual · The announcement (opens in a new tab)
- 23 Jul 2026Resultsdown 2.31%−1.6 pts vs Nifty 500market median −0.7% · five sessions −5.6% (−6.5 pts vs Nifty 500) · volume 7.3× usual · delivery −30.1 pts against usual · The announcement (opens in a new tab)
- 24 Jun 2026Credit ratingdown 1.17%−1.7 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−2.7 pts vs Nifty 500) · volume 0.7× usual · delivery +4.4 pts against usual · The announcement (opens in a new tab)
- 15 May 2026Resultsup 14.22%+14.6 pts vs Nifty 500market median −0.7% · five sessions +11.1% (+11.2 pts vs Nifty 500) · volume 34.6× usual · delivery −36.2 pts against usual · The announcement (opens in a new tab)
- 6 Feb 2026Resultsdown 10.56%−10.7 pts vs Nifty 500market median −0.7% · five sessions −8.8% (−9.8 pts vs Nifty 500) · volume 7.0× usual · delivery −15.0 pts against usual · The announcement (opens in a new tab)
- 8 Dec 2025Board or managers changeddown 0.31%+1.0 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+7.4 pts vs Nifty 500) · volume 0.6× usual · delivery −10.1 pts against usual · The announcement (opens in a new tab)
- 6 Nov 2025Board or managers changeddown 8.82%−8.1 pts vs Nifty 500market median 0.0% · five sessions −10.3% (−11.0 pts vs Nifty 500) · volume 6.5× usual · delivery +1.3 pts against usual · The announcement (opens in a new tab)
- 6 Nov 2025Resultsdown 8.82%−8.1 pts vs Nifty 500market median −0.7% · five sessions −10.3% (−11.0 pts vs Nifty 500) · volume 6.5× usual · delivery +1.3 pts against usual · The announcement (opens in a new tab)
- 25 Jul 2025Resultsup 6.06%+7.3 pts vs Nifty 500market median −0.7% · five sessions −2.3% (−0.7 pts vs Nifty 500) · volume 6.7× usual · delivery −24.3 pts against usual · The announcement (opens in a new tab)
- 2 Jul 2025Credit ratingdown 0.82%−0.5 pts vs Nifty 500market median 0.0% · five sessions −4.3% (−4.1 pts vs Nifty 500) · volume 0.3× usual · delivery +0.3 pts against usual · The announcement (opens in a new tab)
20 earlier announcements
- 15 May 2025Resultsdown 9.90%−11.2 pts vs Nifty 500market median −0.7% · five sessions −16.8% (−17.9 pts vs Nifty 500) · volume 7.0× usual · delivery −19.6 pts against usual · The announcement (opens in a new tab)
- 24 Feb 2025Board or managers changeddown 3.10%−2.0 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−4.5 pts vs Nifty 500) · volume 3.7× usual · delivery −7.3 pts against usual · The announcement (opens in a new tab)
- 24 Jan 2025Resultsdown 8.41%−7.4 pts vs Nifty 500market median −0.7% · five sessions −26.9% (−25.8 pts vs Nifty 500) · volume 6.7× usual · delivery −33.0 pts against usual · The announcement (opens in a new tab)
- 21 Oct 2024Resultsup 1.51%+2.3 pts vs Nifty 500market median −0.7% · five sessions −8.8% (−4.8 pts vs Nifty 500) · volume 3.6× usual · The announcement (opens in a new tab)
- 22 Jul 2024Resultsup 4.99%+4.6 pts vs Nifty 500market median −0.7% · five sessions +12.6% (+10.7 pts vs Nifty 500) · volume 0.4× usual · The announcement (opens in a new tab)
- 30 May 2024Resultsdown 2.94%−1.9 pts vs Nifty 500market median −0.7% · five sessions −7.9% (−6.9 pts vs Nifty 500) · volume 1.1× usual · delivery −14.0 pts against usual · The announcement (opens in a new tab)
- 15 Feb 2024Board or managers changedup 8.47%+7.9 pts vs Nifty 500market median 0.0% · five sessions +32.3% (+31.3 pts vs Nifty 500) · volume 6.4× usual · delivery −15.9 pts against usual · The announcement (opens in a new tab)
- 7 Aug 2023Board or managers changeddown 0.09%−0.5 pts vs Nifty 500market median 0.0% · five sessions +1.0% (+1.2 pts vs Nifty 500) · volume 1.9× usual · delivery −4.6 pts against usual · The announcement (opens in a new tab)
- 1 Aug 2023Board or managers changedup 0.74%+0.8 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−0.6 pts vs Nifty 500) · volume 0.8× usual · delivery +0.6 pts against usual · The announcement (opens in a new tab)
- 20 Jul 2023Board or managers changedup 0.22%−0.3 pts vs Nifty 500market median 0.0% · five sessions +0.9% (+0.8 pts vs Nifty 500) · volume 0.3× usual · delivery −5.2 pts against usual · The announcement (opens in a new tab)
- 25 Jan 2023Resultsup 4.66%+6.1 pts vs Nifty 500market median −0.7% · five sessions −3.3% (+0.2 pts vs Nifty 500) · volume 14.2× usual · delivery −33.5 pts against usual · The announcement (opens in a new tab)
- 5 Aug 2022Board or managers changeddown 2.90%−2.9 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.8 pts vs Nifty 500) · volume 0.7× usual · delivery +1.6 pts against usual · The announcement (opens in a new tab)
- 4 Aug 2022Resultsdown 0.26%−0.4 pts vs Nifty 500market median −0.7% · five sessions −7.7% (−9.1 pts vs Nifty 500) · volume 3.5× usual · delivery −15.3 pts against usual · The announcement (opens in a new tab)
- 2 May 2022Board or managers changeddown 19.99%−19.7 pts vs Nifty 500market median 0.0% · five sessions −26.4% (−21.0 pts vs Nifty 500) · volume 8.2× usual · delivery −3.1 pts against usual · The announcement (opens in a new tab)
- 9 Mar 2022Board or managers changeddown 0.29%−2.3 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−3.0 pts vs Nifty 500) · volume 0.2× usual · delivery +5.6 pts against usual · The announcement (opens in a new tab)
- 28 Feb 2022Board or managers changedup 0.37%−0.5 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+6.9 pts vs Nifty 500) · volume 0.3× usual · delivery +6.5 pts against usual · The announcement (opens in a new tab)
- 10 Feb 2022Board or managers changeddown 20.00%−20.6 pts vs Nifty 500market median 0.0% · five sessions −31.0% (−29.4 pts vs Nifty 500) · volume 1.2× usual · delivery +55.3 pts against usual · The announcement (opens in a new tab)
- 6 May 2021Dividendup 2.31%+1.6 pts vs Nifty 500market median 0.0% · five sessions +8.3% (+7.3 pts vs Nifty 500) · volume 2.4× usual · delivery −13.6 pts against usual · The announcement (opens in a new tab)
- 11 Nov 2020Dividendup 6.20%+5.4 pts vs Nifty 500market median 0.0% · five sessions +7.9% (+5.4 pts vs Nifty 500) · volume 1.6× usual · delivery −4.3 pts against usual · The announcement (opens in a new tab)
- 30 Oct 2020Board or managers changedup 1.88%+2.0 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−6.6 pts vs Nifty 500) · volume 1.3× usual · delivery −20.2 pts against usual · The announcement (opens in a new tab)
Solara Active Pharma Sciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.